실시간
CellMechanism of lipid transfer by bridge-like protein VPS13A and the scramblase XKCellGregory J. Hannon (1964–2026)FierceBiotechLilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’Endpoints NewsBiopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and moreClinical OMICsLong-Read DNA Test Could Replace 15 Existing Tests for Rare Diseases10x Genomics Blog10x Genomics (TXG) Stock Valuation After Recent Surge In Returns - simplywall.stClinical OMICsMaternal Blood Test Allows Comprehensive Genetic Fetal ScreeningEndpoints NewsMerck brings Welireg-Keytruda combo to treat kidney cancerFDA News ReleasesFDA Clears First Over-the-Counter Continuous Glucose Monitor for ChildrenClinical OMICsFrom Multi-Omics to Digital Twins: A Data-Driven Future for Precision MedicineClinical OMICsAge-Related Mutations in Brain Immune Cells Linked to Alzheimer’s InflammationClinical OMICsPaper Mills and the Fight Against Scientific Fraud
BioWorld 2026년 4월 29일

Shanghai Yingli Pharmaceutical synthesizes new OGG1 inhibitors

Shanghai Yingli Pharmaceutical synthesizes new OGG1 inhibitors

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.